Abstract

None of four chemotherapy regimens offered a significant advantage over the others in the treatment of advanced non-small-cell lung cancer.

Keywords

MedicineGemcitabineCarboplatinDocetaxelCisplatinLung cancerInternal medicineRegimenPaclitaxelChemotherapyOncologyConfidence intervalSurvival rate

Affiliated Institutions

Related Publications

Publication Info

Year
2002
Type
article
Volume
346
Issue
2
Pages
92-98
Citations
4924
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

4924
OpenAlex

Cite This

Joan H. Schiller, David Harrington, Chandra P. Belani et al. (2002). Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer. New England Journal of Medicine , 346 (2) , 92-98. https://doi.org/10.1056/nejmoa011954

Identifiers

DOI
10.1056/nejmoa011954